CoChat

Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer

Open access

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Abstract

High Grade Serous Ovarian cancer (HGSOC) is a major unmet need in oncology, due to its precocious dissemination and the lack of meaningful human models for the investigation of disease pathogenesis in a patient-specific manner. To overcome this roadblock, we present a new method to isolate and grow single cells directly from patients' metastatic ascites, establishing the conditions for propagating them as 3D cultures that we refer to as single cell-derived metastatic ovarian cancer spheroids (sMOCS). By single cell RNA sequencing (scRNAseq) we define the cellular composition of metastatic ascites and trace its propagation in 2D and 3D culture paradigms, finding that sMOCS retain and amplify key subpopulations from the original patients' samples and recapitulate features of the original metastasis that do not emerge from classical 2D culture, including retention of individual patients' specificities. By enabling the enrichment of uniquely informative cell subpopulations from HGSOC metastasis and the clonal interrogation of their diversity at the functional and molecular level, this method provides a powerful instrument for precision oncology in ovarian cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41418-021-00878-w

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Generation of sMOCS from HGSOC ascites. a Scheme illustrating the main steps of the method for generating single cell ovarian cancer spheroids (sMOCS) from HGSOC ascites. Ascitic fluid is centrifuged; the cell pellet is processed for the removal of red blood cells and dissociated as single cell suspension for monolayer culture of tumor cells (step 1); the remaining supernatant after the first centrifugation is processed in order to remove the residual fraction of cells and is used as supplement for growing and culturing sMOCS (step 2). Tumor cells from monolayer culture are dissociated, resuspended in specific culture media for growing single cell from HGSOC ascites and plated by limiting dilution at the density of 1 cell per well in a low-adhesion 96 well V bottom plate (step 3). sMOCS at first passage (P1) are observed after 8–12 days in culture as tridimensional structure of about 200–220 μm of diameter and then propagated through dissociation of a single spheroid in single cells. The single cells are resuspended in the described media and plated as previously indicated in order to obtain the next passages in culture (P2 and P3). The scheme illustrates that fresh ascites, monolayer culture of tumor cells, and sMOCS at different passages are then processed for scRNAseq to obtain their transcriptomic profile. b Bright field image analysis (x4magnification for 2D, scale bar 1000 μm; x40 magnification for sMOCS P1, scale bar 400 μm; x20 magnification for sMOCS P2 and P3, scale bar 200 μm).
Fig. 1 Generation of sMOCS from HGSOC ascites. a Scheme illustrating the main steps of the method for generating single cell ovarian cancer spheroids (sMOCS) from HGSOC ascites. Ascitic fluid is centrifuged; the cell pellet is processed for the removal of red blood cells and dissociated as single cell suspension for monolayer culture of tumor cells (step 1); the remaining supernatant after the first centrifugation is processed in order to remove the residual fraction of cells and is used as supplement for growing and culturing sMOCS (step 2). Tumor cells from monolayer culture are dissociated, resuspended in specific culture media for growing single cell from HGSOC ascites and plated by limiting dilution at the density of 1 cell per well in a low-adhesion 96 well V bottom plate (step 3). sMOCS at first passage (P1) are observed after 8–12 days in culture as tridimensional structure of about 200–220 μm of diameter and then propagated through dissociation of a single spheroid in single cells. The single cells are resuspended in the described media and plated as previously indicated in order to obtain the next passages in culture (P2 and P3). The scheme illustrates that fresh ascites, monolayer culture of tumor cells, and sMOCS at different passages are then processed for scRNAseq to obtain their transcriptomic profile. b Bright field image analysis (x4magnification for 2D, scale bar 1000 μm; x40 magnification for sMOCS P1, scale bar 400 μm; x20 magnification for sMOCS P2 and P3, scale bar 200 μm).CC BY · PubMed Central
Fig. 2 Metastatic ascitic fluid is required for cell proliferation and generation of sMOCS. a Bright field images representative of the morphology of primary cultures derived from HGSOC ascites of different patients (x4 magnification for 2D monolayer culture of three different patients, scale bar 1000 μm). b Bright field image analysis (x4 magnification for patient 1, patient 2 and patient 3, scale bar 1000 mm) of a single cell from 3 different patients plated in STEM media only and the respective fluorescent signal for PKH67 + (green). c Bright field image analysis (x4 magnification for patient 1, scale bar 1000 μm; x20 magnification for patient 1, scale bar 200 μm) of a single cell from patient 1 cultured in STEM media supplemented with ascitic fluid and fluorescent signal for PKH67. d Time-lapse of a single well followed during cell division. Day 0: only a single cell is present in the well. Day 2: first mitotic division. Day 4: the small spheroid is formed. Day 5: the small spheroids divide in single cells. Day 6: all the cells derived from the original spheroid start to divide. Day 10: multiple monoclonal spheroids are grown.
Fig. 2 Metastatic ascitic fluid is required for cell proliferation and generation of sMOCS. a Bright field images representative of the morphology of primary cultures derived from HGSOC ascites of different patients (x4 magnification for 2D monolayer culture of three different patients, scale bar 1000 μm). b Bright field image analysis (x4 magnification for patient 1, patient 2 and patient 3, scale bar 1000 mm) of a single cell from 3 different patients plated in STEM media only and the respective fluorescent signal for PKH67 + (green). c Bright field image analysis (x4 magnification for patient 1, scale bar 1000 μm; x20 magnification for patient 1, scale bar 200 μm) of a single cell from patient 1 cultured in STEM media supplemented with ascitic fluid and fluorescent signal for PKH67. d Time-lapse of a single well followed during cell division. Day 0: only a single cell is present in the well. Day 2: first mitotic division. Day 4: the small spheroid is formed. Day 5: the small spheroids divide in single cells. Day 6: all the cells derived from the original spheroid start to divide. Day 10: multiple monoclonal spheroids are grown.CC BY · PubMed Central
Fig. 3 SMOCS forming efficiency increase during passages in vitro. a Scheme illustrating the main steps of the culturing method to derive sMOCS with a dedicated timeline indicating the number of days required in culture for each stage. b Bright field image of representative images of sMOCS from three different patients at three different passages: P1, P2, and P3, (x20 magnification for sMOCS passage 1(P1) for patient 1, 2, and 3; for sMOCS P2 from patient 2 and 3; for sMOCS P3 from patient 3, scale bar 200 μm); (x40 magnification for sMOCS passage 2 from patient 2 and for sMOCS P3 from patient 1 and 2, scale bar 400 μm). c Scatter plot showing the sMOCS forming efficiency (sSFE) as percentage for each patient and for each passage. Primary cultures derived from HGSOC ascites were grown under non-adherent conditions in 96 well plate V bottom in presence of the media supplemented with ascitic fluid to test their ability to generate monoclonal spheroids. The experiment was performed on 4 independent samples. sSFE was calculated as the ratio between number of monoclonal derived spheroids and the number of cells seeded. d Graph showing single cell spheroid forming efficiency (sSFE) (mean + SEM) of sMOCS from different patients at passage 1, 2, and 3. P1 n = 4, P2 n = 4, P3 n = 4. Unpaired t test, *p < 0.05; **p < 0,01; ***p < 0.001.
Fig. 3 SMOCS forming efficiency increase during passages in vitro. a Scheme illustrating the main steps of the culturing method to derive sMOCS with a dedicated timeline indicating the number of days required in culture for each stage. b Bright field image of representative images of sMOCS from three different patients at three different passages: P1, P2, and P3, (x20 magnification for sMOCS passage 1(P1) for patient 1, 2, and 3; for sMOCS P2 from patient 2 and 3; for sMOCS P3 from patient 3, scale bar 200 μm); (x40 magnification for sMOCS passage 2 from patient 2 and for sMOCS P3 from patient 1 and 2, scale bar 400 μm). c Scatter plot showing the sMOCS forming efficiency (sSFE) as percentage for each patient and for each passage. Primary cultures derived from HGSOC ascites were grown under non-adherent conditions in 96 well plate V bottom in presence of the media supplemented with ascitic fluid to test their ability to generate monoclonal spheroids. The experiment was performed on 4 independent samples. sSFE was calculated as the ratio between number of monoclonal derived spheroids and the number of cells seeded. d Graph showing single cell spheroid forming efficiency (sSFE) (mean + SEM) of sMOCS from different patients at passage 1, 2, and 3. P1 n = 4, P2 n = 4, P3 n = 4. Unpaired t test, *p < 0.05; **p < 0,01; ***p < 0.001.CC BY · PubMed Central
Fig. 4 single cell RNAseq reveals enrichment of CICs in sMOCS. a Number of cells for samples and patients analyzed after filtering and quality control. b UMAP of single cell transcriptomes from cells in (a), where each cell is represented by a point; each color tone identifies different conditions among the same patient, yellow tones: fresh ascites; turquoise tones: 2D culture; purple tones: sMOCS;. Top right: the magnification of the central area of the UMAP is enriched mainly for sMOCS cells but also for some fresh ascites and 2D cultured cells. c Diffusion map of single cell transcriptomes from cells in (a), where each cell is a point; yellow tones: fresh ascites; turquoise tones: 2D culture; purple tones: sMOCS. Bottom right: magnification of the region where all the samples from different patients and conditions converge, enriched in sMOCS cells. d–g Enrichment analysis of Cancer stem and EMT signature. Left: diffusion maps of all the conditions and patients with a color scale defined by the z score of the respective signature; right: frequency plot showing the variation in the distribution of cells as a function of the z score of the indicated signature. The higher the percentage of cells with high z score, the more enriched the sample is for the indicated signature.
Fig. 4 single cell RNAseq reveals enrichment of CICs in sMOCS. a Number of cells for samples and patients analyzed after filtering and quality control. b UMAP of single cell transcriptomes from cells in (a), where each cell is represented by a point; each color tone identifies different conditions among the same patient, yellow tones: fresh ascites; turquoise tones: 2D culture; purple tones: sMOCS;. Top right: the magnification of the central area of the UMAP is enriched mainly for sMOCS cells but also for some fresh ascites and 2D cultured cells. c Diffusion map of single cell transcriptomes from cells in (a), where each cell is a point; yellow tones: fresh ascites; turquoise tones: 2D culture; purple tones: sMOCS. Bottom right: magnification of the region where all the samples from different patients and conditions converge, enriched in sMOCS cells. d–g Enrichment analysis of Cancer stem and EMT signature. Left: diffusion maps of all the conditions and patients with a color scale defined by the z score of the respective signature; right: frequency plot showing the variation in the distribution of cells as a function of the z score of the indicated signature. The higher the percentage of cells with high z score, the more enriched the sample is for the indicated signature.CC BY · PubMed Central
Fig. 5 sMOCS capture relevant features of the fresh tissue while preserving hallmarks of HGSOC ascites that do not emerge from 2D culture. a Pathway analysis on the groups of genes and 2D culture; (b) pathway analysis on the groups of genes that correlate among fresh ascites and monoclonal 3D system; (c) heatmap of differentially expressed genes between sMOCS and 2D culture; (d) pathway analysis performed on DEGs in (c): color scale define the predicted activation/deactivation of the pathway; orange identifies the pathways activated in sMOCS; (e) IPA causal network derived from DEGs in (c): color scale define the expression of downstream regulated genes and their associated function, the orange tone identifies the genes and functions activated in sMOCS.
Fig. 5 sMOCS capture relevant features of the fresh tissue while preserving hallmarks of HGSOC ascites that do not emerge from 2D culture. a Pathway analysis on the groups of genes and 2D culture; (b) pathway analysis on the groups of genes that correlate among fresh ascites and monoclonal 3D system; (c) heatmap of differentially expressed genes between sMOCS and 2D culture; (d) pathway analysis performed on DEGs in (c): color scale define the predicted activation/deactivation of the pathway; orange identifies the pathways activated in sMOCS; (e) IPA causal network derived from DEGs in (c): color scale define the expression of downstream regulated genes and their associated function, the orange tone identifies the genes and functions activated in sMOCS.CC BY · PubMed Central
Fig. 6 Drug treatment of sMOCS highlights inter- and intra-patient variability in response. a, b Comparison of the response of sMOCS vs 2D cultures to drug treatment. sMOCS and 2D cultures were treated with carboplatin (untreated, 5 µM, 10 µM, 25 µM, 50 µM, 75 µM). Cell viability was measured with CellTiter-Glo® 3D Cell Viability Assay (for sMOCS) and CellTiter-Glo® Luminescent Cell Viability Assay (for 2D cultures). a Results obtained from three independent naive patient samples, shown as means + SD. P value was calculated by a two-tailed unpaired Student’s t test, and the difference among monoclonal-derived spheroids and 2D cultures resulted statistically significant: 0.0262. b Data obtained from cells derived from a patient sample after chemotherapy (post-chemotherapy), at relapse, shown as means + SD. P value was calculated as above: 0.0454. c, d Intrapatient heterogeneity of response to drug treatment using sMOCS. P2 sMOCS were dissociated and cells seeded at 500 cells/well, and then derived spheroids were treated with carboplatin (untreated, 50 µM, 100 µM, 150 µM, 200 µM) and measured for cell viability as described above. In (c), spheroids at P3 derived from six cancer initiating cells of patient 17AS27 were analysed, in (d) spheroids at P3 derived from five cancer initiating cells of patient 18AS18. P values were determined by a two-tailed unpaired Student’s t test. In (c), the following pairs showed a significant P value: #1 vs #2: 0.0152, #2 vs #4: 0.0304. Comparison of the response of sMOCS vs 2D cultures and intrapatient heterogeneity of response to drug treatment. a After 7 days, cell viability was measured.Response variability shown as percentage error between sMOCS/2D cells derived from 6 patients. b, c Spheroids were treated with carboplatin (untreated, 50 µM, 100 µM, 150 µM, 200 µM) and measured for cell viability. In (b), spheroids derived from six individual cell clones of patient 17As27 were analysed, in (c) spheroids derived from five individual cell clones of patient 18As18.
Fig. 6 Drug treatment of sMOCS highlights inter- and intra-patient variability in response. a, b Comparison of the response of sMOCS vs 2D cultures to drug treatment. sMOCS and 2D cultures were treated with carboplatin (untreated, 5 µM, 10 µM, 25 µM, 50 µM, 75 µM). Cell viability was measured with CellTiter-Glo® 3D Cell Viability Assay (for sMOCS) and CellTiter-Glo® Luminescent Cell Viability Assay (for 2D cultures). a Results obtained from three independent naive patient samples, shown as means + SD. P value was calculated by a two-tailed unpaired Student’s t test, and the difference among monoclonal-derived spheroids and 2D cultures resulted statistically significant: 0.0262. b Data obtained from cells derived from a patient sample after chemotherapy (post-chemotherapy), at relapse, shown as means + SD. P value was calculated as above: 0.0454. c, d Intrapatient heterogeneity of response to drug treatment using sMOCS. P2 sMOCS were dissociated and cells seeded at 500 cells/well, and then derived spheroids were treated with carboplatin (untreated, 50 µM, 100 µM, 150 µM, 200 µM) and measured for cell viability as described above. In (c), spheroids at P3 derived from six cancer initiating cells of patient 17AS27 were analysed, in (d) spheroids at P3 derived from five cancer initiating cells of patient 18AS18. P values were determined by a two-tailed unpaired Student’s t test. In (c), the following pairs showed a significant P value: #1 vs #2: 0.0152, #2 vs #4: 0.0304. Comparison of the response of sMOCS vs 2D cultures and intrapatient heterogeneity of response to drug treatment. a After 7 days, cell viability was measured.Response variability shown as percentage error between sMOCS/2D cells derived from 6 patients. b, c Spheroids were treated with carboplatin (untreated, 50 µM, 100 µM, 150 µM, 200 µM) and measured for cell viability. In (b), spheroids derived from six individual cell clones of patient 17As27 were analysed, in (c) spheroids derived from five individual cell clones of patient 18As18.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 58

Metadata

Authors
Velletri, T., Villa, C. E., Cilli, D., Barzaghi, B., Lo Riso, P., Lupia, M., Luongo, R., López-Tobón, A., De Simone, M., Bonnal, R. J. P., Marelli, L., Piccolo, S., Colombo, N., Pagani, M., Cavallaro, U., Minucci, S., & Testa, G.
Affiliations
  • Cogentech S.R.L. Società Benefit a Socio Unico soggetta all’attività di direzione e coordinamento di IFOM - Istituto Fondazione di Oncologia Molecolare ETS (Italy) (IT)
  • Human Technopole (IT)
  • European Institute of Oncology (IT)
  • Istituto Nazionale Genetica Molecolare (IT)
  • University of Padua (IT)
  • University of Milan (IT)
Corresponding author
  • Minucci, Saverio
  • Testa, Giuseppe
Venue
Cell Death & Differentiation
Published
2021-11-29
Volume
29
Issue
3
Pages
614-626
ISSN
  • 1350-9047 (ISSN-L)
  • 1476-5403
OpenAlex
W3217446792
Cited by
48
References
61
Citations by year
2026: 9 · 2025: 12 · 2024: 9 · 2023: 13 · 2022: 3 · 2021: 1
FWCI
5.60
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Differentiation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
  • Lirias (submittedVersion, cc-by)
  • BOA (University of Milano-Bicocca) (submittedVersion, cc-by)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Funders
Fondazione AIRC per la Ricerca sul Cancro EPIGEN Flagship Project
Topics
  • Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
high-grade serous ovarian cancer, 3D cell culture, tumor cell subpopulations, self-renewal, clonal diversity, precision oncology, single-cell RNA sequencing
MeSH terms
Ascites, Female, Humans, Ovarian Neoplasms, Spheroids, Cellular, Cell Line, Tumor, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer. https://app.cochat.ai/papers/10.1038/s41418-021-00878-w
The paper
Velletri, T., Villa, C. E., Cilli, D., Barzaghi, B., Lo Riso, P., Lupia, M., Luongo, R., López-Tobón, A., De Simone, M., Bonnal, R. J. P., Marelli, L., Piccolo, S., Colombo, N., Pagani, M., Cavallaro, U., Minucci, S., & Testa, G. (2022). Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer. Cell Death & Differentiation. https://doi.org/10.1038/s41418-021-00878-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.